SciELO - Scientific Electronic Library Online

 
vol.21 suppl.3Clinical consequences of sarcopeniaPhysiologic particularities of muscle impairments in the patient with COPD author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nutrición Hospitalaria

On-line version ISSN 1699-5198Print version ISSN 0212-1611

Abstract

BURGOS PELAEZ, R.. Global therapeutica approach to sarcopenia. Nutr. Hosp. [online]. 2006, vol.21, suppl.3, pp.51-60. ISSN 1699-5198.

Sarcopenia is the loss of skeletal muscle mass that occurs with ageing, and is a major contributing factor to disability and loss of independence in the elderly. The etiopathogenesis involves a number of underlying mechanisms including intrinsic changes in the muscle and central nervous system, and hormonal and lifestyle factors. Many hormones and cytokines affect muscle mass and function. Reductions in testosterone and estrogens that accompany ageing appear to accelerate loss of muscle mass. Growth hormone has been hypothesised to contribute to loss of lean body mass. Although sarcopenia is not completely reversed with exercise, physical inactivity leads to accelerated muscle loss. The diagnosis of sarcopenia is difficult because the most reliable methods to measure muscle mass are not easily available. Various treatment strategies have been tested for combating the loss of muscle mass: testosterone replacement and other anabolic androgens for men, estrogen replacement in women, growth hormone replacement, nutritional treatment and physical training. Only high resistance exercise training has been effective in increasing muscle mass, with or without nutritional supplementation.

Keywords : Sarcopenia; Ageing; Muscular atrophy.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License